[go: up one dir, main page]

TR201000686A1 - Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@ - Google Patents

Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@

Info

Publication number
TR201000686A1
TR201000686A1 TR2010/00686A TR201000686A TR201000686A1 TR 201000686 A1 TR201000686 A1 TR 201000686A1 TR 2010/00686 A TR2010/00686 A TR 2010/00686A TR 201000686 A TR201000686 A TR 201000686A TR 201000686 A1 TR201000686 A1 TR 201000686A1
Authority
TR
Turkey
Prior art keywords
cefdinir
soluble
treatment
clavulanic acid
water
Prior art date
Application number
TR2010/00686A
Other languages
English (en)
Inventor
B�Lg�� Mahmut
Original Assignee
B�Lg�� Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B�Lg�� Mahmut filed Critical B�Lg�� Mahmut
Priority to TR2010/00686A priority Critical patent/TR201000686A1/tr
Priority to PCT/TR2011/000031 priority patent/WO2011093827A1/en
Priority to PCT/TR2011/000025 priority patent/WO2011093821A1/en
Priority to EP11706649A priority patent/EP2528584A1/en
Publication of TR201000686A1 publication Critical patent/TR201000686A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş bakterilerin neden olduğu dirençli enfeksiyon hastalıklarının tedavisinde oral kullanıma uygun suda çözünebilir sefdinir ve klavulanik asit ve/ veya bunların farmasötik kabul edilebilir tuzları, hidratları, enantiomerleri, rasematları, organik tuzları, inorganik tuzları, esterleri, polimorflan, kristal formları ve amorf formlarını ve/veya bunlara ait kombinasyonları içeren farmasötik formulasyonlara ilişkindir.
TR2010/00686A 2010-01-29 2010-01-29 Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@ TR201000686A1 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2010/00686A TR201000686A1 (tr) 2010-01-29 2010-01-29 Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
PCT/TR2011/000031 WO2011093827A1 (en) 2010-01-29 2011-01-28 Water dispersible cefdinir and clavulanic acid formulations for treatment of bacterial infections
PCT/TR2011/000025 WO2011093821A1 (en) 2010-01-29 2011-01-28 Effervescent formulations comprising cefdinir and clavulanic acid
EP11706649A EP2528584A1 (en) 2010-01-29 2011-01-28 Water dispersible cefdinir and clavulanic acid formulations for treatment of bacterial infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/00686A TR201000686A1 (tr) 2010-01-29 2010-01-29 Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@

Publications (1)

Publication Number Publication Date
TR201000686A1 true TR201000686A1 (tr) 2011-08-22

Family

ID=43829127

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/00686A TR201000686A1 (tr) 2010-01-29 2010-01-29 Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@

Country Status (3)

Country Link
EP (1) EP2528584A1 (tr)
TR (1) TR201000686A1 (tr)
WO (2) WO2011093827A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095313A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Pharmaceutical formulations comprising cefdinir
EP3694493A1 (en) * 2017-10-13 2020-08-19 Alfred E. Tiefenbacher (GmbH & Co. KG) Tablet containing valsartan and sacubitril
CN111000805B (zh) * 2020-01-03 2021-10-19 深圳市贝美药业有限公司 舒他西林颗粒制剂及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
ZA836918B (en) 1982-09-30 1984-05-30 Fujisawa Pharmaceutical Co 7-substituted-3-vinyl-3-cephem compounds and processes for the production of the same
DK162718C (da) 1982-09-30 1992-05-11 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af 7-substitueret-3-vinyl-3-cephemforbindelser
ZA885709B (en) 1987-08-19 1989-04-26 Fujisawa Pharmaceutical Co Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid(syn isomer)
GB9408117D0 (en) 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
ATE208618T1 (de) 1995-09-07 2001-11-15 Smithkline Beecham Corp Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
NZ330864A (en) * 1996-02-29 2001-07-27 Fujisawa Pharmaceutical Co Beta-lactam antibiotic-containing tablet including a disintegrant and a binder
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
AU2869100A (en) * 1999-02-26 2000-09-14 Biovail International Ltd. Storage stable amoxycillin and clavulanate suspension composition
ES2202004T3 (es) 1999-04-13 2004-04-01 Beecham Pharmaceuticals (Pte) Limited Novedoso procedimiento de tratamiento usando un fuerte regimen de dosificacion de amoxicilina y clavulanato potasico.
WO2004104010A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Crystalline form of cefdinir
US20060069079A1 (en) 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
GB0416379D0 (en) 2004-07-22 2004-08-25 Sandoz Ag Organic compounds
CN1706389A (zh) * 2005-05-26 2005-12-14 济南平志医药科技有限公司 头孢地尼泡腾制剂及其制备方法
EP1943256A2 (en) 2005-10-31 2008-07-16 Teva Pharmaceutical Industries Ltd. Crystalline forms of cefdinir potassium salt
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
US20090275552A1 (en) * 2006-04-28 2009-11-05 Mahesh Vithalbhai Patel Therapy for Treating Resistant Bacterial Infections
US20080103124A1 (en) * 2006-10-25 2008-05-01 Astellas Pharma Inc. Cefdinir-containing pharmaceutical composition
TR200909787A2 (tr) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.

Also Published As

Publication number Publication date
WO2011093827A1 (en) 2011-08-04
WO2011093821A1 (en) 2011-08-04
EP2528584A1 (en) 2012-12-05

Similar Documents

Publication Publication Date Title
WO2011093826A3 (en) Effervescent formulations comprising cefaclor and clavulanic acid as active agents
TN2014000417A1 (en) Heterobicyclic compounds as beta-lactamase inhibitors
CR20110195A (es) Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas
BR112012001987A2 (pt) Composto, combinação, formulação farmacêutica, uso de um composto, uma combinação ou um sal farmaceuticamente aceitável dos mesmos, e, métodos para tratar uma infecção bacteriana, para matar ou inibir o crescimento de uma bactéria, e para inibir uma beta-lactamase.
CL2013000399A1 (es) Compuestos derivados de ester de acido boronico; composicion farmaceutica; recipiente esteril; metodo de preparacion; y su uso para el tratamiento o la prevencion de una infeccion bacteriana.
PH12016501577B1 (en) Monobactam organic compounds for the treatment of bacterial infections
PH12012502568A1 (en) Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts
HUE059033T2 (hu) Benzoxaborol-származékok bakteriális fertõzések kezelésére
MX375925B (es) Compuestos imidazo[1,2-a]pirazin-1-il-benzamida para tratar atrofia muscular espinal.
MX2013002851A (es) Inhibidores de tonum pectinacetilesterasa y metodos de su uso.
WO2014022382A3 (en) Antibacterial protein kinase inhibitors
EP2601967A4 (en) MEDICINE FOR PREVENTING AND TREATING HIV-RELATED OR HIV-RELATED DISEASES, INCLUDING AIDS
MX369025B (es) Inhibidores de aldosterona sintasa.
EA201890412A1 (ru) АНТИБАКТЕРИАЛЬНЫЕ АГЕНТЫ, СОДЕРЖАЩИЕ ПИРАЗИНО[2,3-b][1,4]ОКСАЗИН-3-ОН ИЛИ РОДСТВЕННУЮ КОЛЬЦЕВУЮ СИСТЕМУ
TR201005325A2 (tr) Atorvastatin ve aspirin içeren farmasötik formülasyonlar
TR201000686A1 (tr) Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
ECSP11011053A (es) [4-(1-amino-etil)-ciclohexil]-metil-aminas como antibacterianos
MX339619B (es) Formulaciones, sales y polimorfos de transnorsertralina y usos de los mismos.
HK1216721A1 (zh) 治疗肝脏疾病或病状的用途和方法
TR201000689A1 (tr) Sefprozil içeren katı dozaj formlar.
CL2010001590A1 (es) Compuestos derivados de 3-(n-heterociclil)-pirrolidin-feniloxazolidinonas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para el tratamiento de infecciones bacterianas
TR201106004A2 (tr) Sefalosporin türevinin farmasotik bir bileşim içerisinde kullanımı.
TR201000683A2 (tr) Formoterol ve siklesonit içeren farmasötik bileşimler.
TN2010000418A1 (en) Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts
WO2014033744A3 (en) A novel pharmaceutical composition of linezolid